Navigation Links
USC wins $56.8M NIH award for clinical and translational research
Date:7/15/2010

The University of Southern California (USC) has received a prestigious $56.8 million Clinical and Translational Science Award from the National Institutes of Health (NIH) to support and promote scientific discoveries and their application in real-life settings to health and health care. The CTSA will have an important focus on health issues of people living in densely populated urban environments.

The award, which will be distributed over the next five years, was given to the USC-based Los Angeles Basin Clinical and Translational Science Institute (CTSI). CTSI was established in 2006 to connect basic scientists to clinical and community researchers and practitioners with a goal of accelerating the translation of laboratory discoveries into practice. Principal investigator is Thomas A. Buchanan, M.D., director of the Los Angeles Basin CTSI, and associate dean for clinical research at the Keck School of Medicine of USC.

"We congratulate principal investigator Dr. Tom Buchanan and the highly interdisciplinary USC team for winning this award," said Carmen A. Puliafito, M.D., M.B.A., dean of the Keck School of Medicine. "An extraordinarily strong grant application resulted in USC receiving the first Clinical and Translational Science Award in Los Angeles." The application received a score of 12 on a scale of 10 to 90 (10 is a perfect score).

Faculty from eight USC schools and Childrens Hospital Los Angeles will partner with Kaiser Permanente Southern California, the Los Angeles County departments of Health Services and Mental Health, the Community Clinic Association of Los Angeles County, and more than 30 community health organizations in greater Los Angeles to address the specific needs of the urban and diverse patient populations found in USC's backyard of downtown Los Angeles.

"We positioned our CTSI as not only an institute focused on health research, but also as a partnership among some of the largest providers of health care in Los Angeles. We are working collaboratively with others on campus and off campus, using L.A. as a real world laboratory to address issues that are important to the community here," Buchanan said.

With this award, USC joins a consortium of 55 health research centers in 28 states and the District of Columbia that are developing new ways to advance medical research in many disease areas and conditions, including cancer, mental illness, neurological disorders, cardiovascular disease, diabetes and obesity.

The selected research institutions work together as a national consortium to improve the way biomedical research is conducted across the country. The consortium, funded through the Clinical and Translational Science Awards (CTSA), shares a common vision to reduce the time it takes for laboratory discoveries to become treatments for patients, and to engage communities in clinical research efforts. It also is fulfilling the critical need to train a new generation of clinical researchers. The CTSA program is led by the National Center for Research Resources, part of National Institutes of Health.

USC competed for the award against 38 other institutions, including three major academic institutions in Southern California. Nine institutions received grant awards this year, and the NIH has stated that it plans to implement a maximum of 60 Clinical and Translational Science Awards overall.

While USC's Los Angeles Basin CTSI has already been successful at launching community research and interdisciplinary projects on a small scale, large-scale funding from the new NIH award will open the doors to development of a premier clinical and translational institute with the potential for a very large impact on health research and health care.

The Los Angeles Basin CTSI has four main goals for the CTSA. The first is to create an integrated academic environment that promotes and supports clinical and translational research. The second is to develop new interdisciplinary teams and projects to address top research priorities and health issues of people living in urban environments. The third is to train a new generation of investigators for clinical and translational science. The fourth goal is to share research findings locally, through the CTSI partnership, and nationally, through the consortium of institutions with CTSAs, to foster better health.

The CTSI has secured participation of eight schools at USC, including Medicine, Cinematic Arts, Dentistry, Education, Engineering, Law, Pharmacy and Social Work.

Some interdisciplinary projects are currently under way. For example, leveraging talent from health sciences, engineering, cinema and informatics, faculty members recently developed an interactive computer game that helps autistic children better interact on an emotional level, one of the deficits of those with the disorder.


'/>"/>

Contact: Leslie Ridgeway
leslie.ridgeway@usc.edu
323-442-2823
University of Southern California
Source:Eurekalert

Related biology news :

1. NIH doles out $3M in new innovator awards to 2 UC San Diego faculty
2. Wistar Institute researcher receives New Innovator award from NIH
3. Stevens awarded $1M for advanced biofuels research
4. NIH awards Clemson bioengineer $1.5 million to improve durability of tissue heart valves
5. L-1 Identity Solutions Awarded New Massachusetts RMV Drivers License Contract Valued at an Estimated $32 Million
6. Entomological Society of America names 2008 award winners
7. 8 National Medals of Science awardees to be honored at gala, then the White House
8. BIO-keys(R) Law Enforcement Group Awarded $700,000 in New Contracts
9. Broad Institute awarded major grant to bolster epigenomics research
10. Entertainment Software Association Foundation awards grant to FAS for immune attack
11. Audience Selected as Silver Winner in This Years Wall Street Journal Technology Innovation Awards and Winner of the Semiconductors Category
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network for ... Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is to ... are designed, built and brought to market. , The Design Lab is Supplyframe’s ...
(Date:6/23/2016)... BEACH, Calif. , June 23, 2016  Blueprint ... new biological discoveries to the medical community, has closed ... co-founder Matthew Nunez . "We have ... us with the capital we need to meet our ... will essentially provide us the runway to complete validation ...
Breaking Biology Technology: